GSK's Moncef Slaoui joins the board at Moderna; Aduro promotes van Elsas to CSO
→ AnaptysBio CSO Matthew Moyle has abruptly resigned and left the company. An SEC filing notes he got nine months salary as severance.
→ Andrea van Elsas, the chief scientific officer of Aduro Biotech Europe, will be appointed chief scientific officer of the mother company Aduro Biotech in Berkley, CA.
→ Moncef Slaoui, the former R&D and vaccines chief at GlaxoSmithKline, is joining the board at the mRNA company Moderna. Slaoui is an enthusiastic champion of pioneering drug R&D. And he says he’s looking “forward to working with the team to navigate this uncharted territory, and support the strategic planning already underway as Moderna works to deliver mRNA medicines and vaccines to address serious unmet medical needs in the U.S. and globally.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.